In short
Recent clinical trials are investigating the use of Betula Alba Pollen Extract, commonly known as birch pollen extract, in the treatment of allergies. These studies aim to assess the efficacy and safety of sublingual immunotherapy for patients suffering from birch pollen allergy and moderate-to-severe allergic rhinitis or rhinoconjunctivitis. The trials focus on determining the most effective and best-tolerated dose of the medication, evaluating its impact on symptoms and quality of life for allergy sufferers.
At a glance
- Study Type
- Phase II-III clinical trials
- Main Objective
- Assess efficacy and safety of sublingual immunotherapy with Betula Alba Pollen Extract
- Target Condition
- Moderate-to-severe allergic rhinitis/rhinoconjunctivitis due to birch pollen
- Primary Endpoint
- Differences in Combined Symptom and Medication Score (CSMS) during peak pollen period
- Key Inclusion Criteria
- Adults 18-65, birch pollen allergy for 2+ years, positive skin prick test and IgE levels
- Key Exclusion Criteria
- Recent immunotherapy, severe asthma, serious systemic reactions to immunotherapy
- Treatment Form
- Sublingual spray or solution
- Secondary Outcomes
- Quality of life, symptom-free days, nasal provocation test results
What is Betula Alba Pollen Extract?
Betula Alba Pollen Extract is a substance derived from birch tree pollen. It is used in various medical products, including solutions for skin-prick tests and nasal sprays for allergy treatment. This extract is being studied as a potential treatment for people who suffer from birch pollen allergies.
Medical Conditions Treated
The primary condition treated with Betula Alba Pollen Extract is moderate-to-severe allergic rhinitis or rhinoconjunctivitis caused by birch pollen. These terms might sound complicated, so let's break them down:
- Allergic rhinitis: This is the medical term for hay fever, which causes symptoms like sneezing, runny nose, and nasal congestion.
- Rhinoconjunctivitis: This condition affects both the nose and eyes, causing symptoms like itchy, watery eyes in addition to nasal symptoms.
These allergies are specifically related to birch pollen and must have been present for at least two years to be considered for this treatment.
How It Works
Betula Alba Pollen Extract is used in a treatment called sublingual immunotherapy (SLIT). Here's how it works:
- The extract is given as a spray under the tongue.
- Regular exposure to small amounts of the allergen (birch pollen) helps the immune system become less sensitive over time.
- This can lead to a reduction in allergy symptoms when exposed to birch pollen in the environment.
Administration and Dosage
The extract is typically administered in two forms:
- Nasal spray: Used for nasal provocation tests, with a maximum daily dose of 1 ml and a maximum total dose of 1.6 ml over a 2-day period.
- Skin-prick test solution: Applied topically, with a maximum dose of 1 drop.
The exact dosage for treatment is still being studied in clinical trials to determine the most effective and best-tolerated dose.
Effectiveness
The effectiveness of Betula Alba Pollen Extract is currently being evaluated in clinical trials. Researchers are looking at several measures to determine how well it works:
- Combined Symptom and Medication Score (CSMS): This score measures both the severity of allergy symptoms and the amount of medication needed to control them.
- Quality of life: Researchers are using questionnaires to assess how the treatment affects patients' overall well-being and daily activities.
- Symptom-free days: The number of days without allergy symptoms or need for medication is being tracked.
Safety and Side Effects
While the full safety profile is still being studied, some potential side effects and safety concerns include:
- Reactions at the site of administration (mouth or nose)
- Potential for allergic reactions
- Interactions with other medications or medical conditions
It's important to note that safety is a key focus of the ongoing clinical trials.
Who Can Use This Treatment?
The treatment is being studied in adults aged 18-65 who meet specific criteria, including:
- Confirmed birch pollen allergy through skin prick tests and blood tests
- Moderate to severe allergy symptoms
- No history of severe allergic reactions to immunotherapy
- No severe asthma or other serious health conditions
There are also several exclusion criteria, such as pregnancy, certain medical conditions, and use of specific medications.
Ongoing Research
Betula Alba Pollen Extract is currently being studied in Phase II-III clinical trials. These studies aim to:
- Determine the most effective dose
- Assess the safety and tolerability of different doses
- Measure the impact on allergy symptoms and quality of life
- Evaluate long-term effectiveness
The results of these trials will help determine if this treatment becomes more widely available for people with birch pollen allergies.